<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi>, a key intermediate in <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, was explored as a potential treatment in models of experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> was administered to rodents after the <z:hpo ids='HP_0003674'>onset</z:hpo> of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Since the extent of <z:mp ids='MP_0001845'>inflammation</z:mp> is often proportional to the size of the <z:mpath ids='MPATH_124'>infarct</z:mpath>, we also studied a group of animals given <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) to cause <z:mp ids='MP_0001847'>brain inflammation</z:mp> without cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Following MCAO, <z:chebi fb="1" ids="15361">pyruvate</z:chebi> did not affect physiological parameters but significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, improved behavioral tests and reduced numbers of neutrophils, microglial and NFkappaB activation </plain></SENT>
<SENT sid="4" pm="."><plain>Animals given LPS showed increased microglial and NFkappaB activation which was almost completely abolished by <z:chebi fb="1" ids="15361">pyruvate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="4" ids="24996">Lactate</z:chebi>, a major metabolite of <z:chebi fb="1" ids="15361">pyruvate</z:chebi>, was increased after <z:chebi fb="1" ids="15361">pyruvate</z:chebi> administration </plain></SENT>
<SENT sid="6" pm="."><plain>However, administration of <z:chebi fb="4" ids="24996">lactate</z:chebi> itself did not have any anti-inflammatory effects </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> protects against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> possibly by blocking <z:mp ids='MP_0001845'>inflammation</z:mp>, but <z:chebi fb="4" ids="24996">lactate</z:chebi> itself does not appear to explain <z:chebi fb="1" ids="15361">pyruvate</z:chebi>'s anti-inflammatory properties </plain></SENT>
</text></document>